PDB Short entry for 1S1R HEADER OXIDOREDUCTASE 07-JAN-04 1S1R TITLE CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN TITLE 2 COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC TITLE 3 ACID AND INDOMETHACIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDO-KETO REDUCTASE FAMILY 1 MEMBER C3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AKR1C3, PROSTAGLANDIN D2 11-KETOREDUCTASE, PROSTAGLANDIN F COMPND 5 SYNTHASE, 3-ALPHA-HSD-TYPE-2, 17-BETA-HSD-TYPE-5; COMPND 6 EC: 1.1.1.213, 1.3.1.20, 1.1.1.62; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET21B KEYWDS TIM-BARREL, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR A.L.LOVERING,J.P.RIDE,C.M.BUNCE,J.C.DESMOND,S.M.CUMMINGS,S.A.WHITE REVDAT 3 25-OCT-23 1S1R 1 REMARK SEQADV REVDAT 2 24-FEB-09 1S1R 1 VERSN REVDAT 1 23-MAR-04 1S1R 0 JRNL AUTH A.L.LOVERING,J.P.RIDE,C.M.BUNCE,J.C.DESMOND,S.M.CUMMINGS, JRNL AUTH 2 S.A.WHITE JRNL TITL CRYSTAL STRUCTURES OF PROSTAGLANDIN D(2) 11-KETOREDUCTASE JRNL TITL 2 (AKR1C3) IN COMPLEX WITH THE NONSTEROIDAL ANTI-INFLAMMATORY JRNL TITL 3 DRUGS FLUFENAMIC ACID AND INDOMETHACIN. JRNL REF CANCER RES. V. 64 1802 2004 JRNL REFN ISSN 0008-5472 JRNL PMID 14996743 JRNL DOI 10.1158/0008-5472.CAN-03-2847 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 23370 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.160 REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.196 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1184 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 665 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE SET COUNT : 28 REMARK 3 BIN FREE R VALUE : 0.3130 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2532 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 294 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.91000 REMARK 3 B22 (A**2) : 0.91000 REMARK 3 B33 (A**2) : -1.36000 REMARK 3 B12 (A**2) : 0.45000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.159 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.140 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.097 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.639 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2655 ; 0.009 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2379 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3602 ; 1.233 ; 1.990 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5564 ; 0.797 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 315 ; 5.935 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 393 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2884 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 515 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 538 ; 0.198 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2808 ; 0.231 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1432 ; 0.081 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 232 ; 0.152 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 4 ; 0.152 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 32 ; 0.255 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 21 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1588 ; 0.497 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2567 ; 0.958 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1067 ; 1.550 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1035 ; 2.635 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 6 A 321 REMARK 3 RESIDUE RANGE : A 1001 A 1001 REMARK 3 RESIDUE RANGE : A 2001 A 2002 REMARK 3 ORIGIN FOR THE GROUP (A): 36.5070 -20.4940 49.2630 REMARK 3 T TENSOR REMARK 3 T11: 0.0091 T22: 0.0227 REMARK 3 T33: 0.0748 T12: 0.0143 REMARK 3 T13: -0.0028 T23: -0.0063 REMARK 3 L TENSOR REMARK 3 L11: 0.5242 L22: 0.7171 REMARK 3 L33: 1.0253 L12: 0.0321 REMARK 3 L13: 0.1646 L23: 0.3806 REMARK 3 S TENSOR REMARK 3 S11: -0.0168 S12: 0.0270 S13: -0.0050 REMARK 3 S21: -0.0211 S22: -0.0003 S23: -0.0228 REMARK 3 S31: -0.0465 S32: -0.0286 S33: 0.0171 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1S1R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-JAN-04. REMARK 100 THE DEPOSITION ID IS D_1000021257. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-SEP-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24691 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.8 REMARK 200 DATA REDUNDANCY : 10.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 1.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1IHI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG, PH 4.6, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 137.44533 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 68.72267 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 68.72267 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 137.44533 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 SER A 3 REMARK 465 LYS A 4 REMARK 465 GLN A 5 REMARK 465 GLU A 322 REMARK 465 TYR A 323 REMARK 465 LEU A 324 REMARK 465 GLU A 325 REMARK 465 HIS A 326 REMARK 465 HIS A 327 REMARK 465 HIS A 328 REMARK 465 HIS A 329 REMARK 465 HIS A 330 REMARK 465 HIS A 331 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 282 O HOH A 2083 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 132 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP A 309 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 51 -167.07 -129.02 REMARK 500 PHE A 197 70.23 -158.86 REMARK 500 SER A 221 169.51 69.43 REMARK 500 ARG A 250 -152.15 -126.66 REMARK 500 ARG A 301 26.04 -142.28 REMARK 500 ASN A 307 78.70 -155.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 2002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1S1P RELATED DB: PDB REMARK 900 ACETATE COMPLEX IN ALTERNATIVE SPACE GROUP REMARK 900 RELATED ID: 1S2A RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH INDOMETHACIN, ALTERNATIVE SPACE REMARK 900 GROUP REMARK 900 RELATED ID: 1S2C RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH FLUFENAMIC ACID, ALTERNATIVE SPACE REMARK 900 GROUP DBREF 1S1R A 1 323 UNP P42330 AK1C3_HUMAN 1 323 SEQADV 1S1R LEU A 324 UNP P42330 EXPRESSION TAG SEQADV 1S1R GLU A 325 UNP P42330 EXPRESSION TAG SEQADV 1S1R HIS A 326 UNP P42330 EXPRESSION TAG SEQADV 1S1R HIS A 327 UNP P42330 EXPRESSION TAG SEQADV 1S1R HIS A 328 UNP P42330 EXPRESSION TAG SEQADV 1S1R HIS A 329 UNP P42330 EXPRESSION TAG SEQADV 1S1R HIS A 330 UNP P42330 EXPRESSION TAG SEQADV 1S1R HIS A 331 UNP P42330 EXPRESSION TAG SEQRES 1 A 331 MET ASP SER LYS GLN GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 A 331 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 A 331 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS SEQRES 4 A 331 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 A 331 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 A 331 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 A 331 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG SEQRES 8 A 331 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS SEQRES 9 A 331 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 A 331 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO SEQRES 11 A 331 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP SEQRES 12 A 331 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP SEQRES 13 A 331 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 A 331 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 A 331 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 A 331 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 A 331 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 A 331 GLN ARG ASP LYS ARG TRP VAL ASP PRO ASN SER PRO VAL SEQRES 19 A 331 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 A 331 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 A 331 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 A 331 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 A 331 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU SEQRES 24 A 331 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA SEQRES 25 A 331 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR LEU GLU SEQRES 26 A 331 HIS HIS HIS HIS HIS HIS HET ACT A2001 4 HET NAP A1001 48 HET MPD A2002 8 HETNAM ACT ACETATE ION HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 ACT C2 H3 O2 1- FORMUL 3 NAP C21 H28 N7 O17 P3 FORMUL 4 MPD C6 H14 O2 FORMUL 5 HOH *294(H2 O) HELIX 1 1 ARG A 31 GLY A 45 1 15 HELIX 2 2 ALA A 52 ASN A 56 5 5 HELIX 3 3 ASN A 57 ASP A 71 1 15 HELIX 4 4 LYS A 75 ILE A 79 5 5 HELIX 5 5 TRP A 86 HIS A 90 5 5 HELIX 6 6 ARG A 91 GLN A 107 1 17 HELIX 7 7 ASP A 143 ALA A 157 1 15 HELIX 8 8 ASN A 169 ASN A 178 1 10 HELIX 9 9 ARG A 199 LYS A 209 1 11 HELIX 10 10 VAL A 234 GLU A 237 5 4 HELIX 11 11 ASP A 238 LYS A 249 1 12 HELIX 12 12 THR A 251 ARG A 263 1 13 HELIX 13 13 ASN A 273 VAL A 281 1 9 HELIX 14 14 GLN A 282 PHE A 286 5 5 HELIX 15 15 THR A 289 GLY A 298 1 10 HELIX 16 16 SER A 308 SER A 313 1 6 SHEET 1 A 2 CYS A 7 LYS A 9 0 SHEET 2 A 2 PHE A 15 PRO A 17 -1 O MET A 16 N VAL A 8 SHEET 1 B 9 LEU A 19 GLY A 22 0 SHEET 2 B 9 HIS A 48 ASP A 50 1 O HIS A 48 N PHE A 21 SHEET 3 B 9 PHE A 80 LEU A 85 1 O THR A 82 N ILE A 49 SHEET 4 B 9 VAL A 111 ILE A 116 1 O LEU A 115 N LEU A 85 SHEET 5 B 9 ALA A 160 SER A 166 1 O LYS A 161 N VAL A 111 SHEET 6 B 9 CYS A 188 GLU A 192 1 O CYS A 188 N VAL A 165 SHEET 7 B 9 VAL A 212 TYR A 216 1 O TYR A 216 N VAL A 191 SHEET 8 B 9 VAL A 266 LYS A 270 1 O VAL A 266 N ALA A 215 SHEET 9 B 9 LEU A 19 GLY A 22 1 N GLY A 20 O VAL A 267 SITE 1 AC1 4 TYR A 55 HIS A 117 NAP A1001 HOH A2153 SITE 1 AC2 34 GLY A 22 THR A 23 TYR A 24 ASP A 50 SITE 2 AC2 34 TYR A 55 HIS A 117 SER A 166 ASN A 167 SITE 3 AC2 34 GLN A 190 TYR A 216 SER A 217 ALA A 218 SITE 4 AC2 34 LEU A 219 GLY A 220 SER A 221 GLN A 222 SITE 5 AC2 34 LEU A 236 ALA A 253 LEU A 268 ALA A 269 SITE 6 AC2 34 LYS A 270 SER A 271 TYR A 272 ARG A 276 SITE 7 AC2 34 GLN A 279 ASN A 280 ACT A2001 HOH A2003 SITE 8 AC2 34 HOH A2016 HOH A2052 HOH A2116 HOH A2153 SITE 9 AC2 34 HOH A2182 HOH A2220 SITE 1 AC3 6 TRP A 86 MET A 120 LEU A 122 SER A 129 SITE 2 AC3 6 PHE A 311 HOH A2013 CRYST1 57.917 57.917 206.168 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017266 0.009969 0.000000 0.00000 SCALE2 0.000000 0.019937 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004850 0.00000